Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery

Journal of Cataract and Refractive Surgery

Volumn 33, Issue 1, 2007, Pages 59-62

  Ong Tone, Lindsay ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTOLATE; DICLOFENAC; EYE DROPS; GATIFLOXACIN; MOXIFLOXACIN; PHENYLEPHRINE; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIMICROBIAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG MIXTURE; DRUG PENETRATION; ENDOPHTHALMITIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYDRIASIS; NONHUMAN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AQUEOUS HUMOR; AZA COMPOUNDS; BIOLOGICAL AVAILABILITY; CATARACT EXTRACTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOROQUINOLONES; HUMANS; INSTILLATION, DRUG; LENS IMPLANTATION, INTRAOCULAR; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; QUINOLINES;

EID: 33845776986     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2006.09.015     Document Type: Article

References (8)

1. Ong-Tone L. Use of a wick to deliver preoperative mydriatics for cataract surgery. J Cataract Refract Surg 29 (2003) 2060-2062
2. Leaming D.V. Practice styles and preferences of ASCRS members-2002 survey. J Cataract Refract Surg 29 (2003) 1412-1420
3. Kowalski R.P., Karenchak L.M., and Romanowski E.G. Infectious disease: changing antibiotic susceptibility. Ophthalmol Clin North Am 16 1 (2003) 1-9
4. Levine J.M., Noecker R.J., Lane L.C., et al. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg 30 (2004) 2177-2182
5. Hariprasad S.M., Mieler W.F., Shah G.K., et al. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Trans Am Ophthalmol Soc 102 (2004) 149-155 discussion, 155-157
6. Kim D.H., Stark W.J., and O'Brien T.P. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into aqueous humor following topical administration prior to routine cataract surgery. Curr Med Res Opin 21 1 (2005) 93-94
7. Leaming D.V. Practice styles and preferences of ASCRS members-2003 survey. J Cataract Refract Surg 30 (2004) 892-900
8. Mather R., Karenchak L.M., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133 (2002) 463-466